【12月15日IPO雷达】健信超导申购

Group 1 - The company, Jianxin Superconductor, is set to issue shares at a price of 18.58 yuan, with a total market value of 2.337 billion yuan and an issuance price-to-earnings ratio of 61.97 [2] - The main business of the company includes the production of medical magnetic resonance imaging (MRI) equipment, superconducting magnets, and gradient coils, making it the largest producer of medical MRI superconducting magnets globally with a market share of 4.2% [2][3] - The company's revenue composition is primarily from superconducting products (73.17%) and permanent magnet products (26.83%) [2] Group 2 - The company has been involved in the development of non-evaporative superconducting magnets since 2015, breaking the long-standing monopoly of European, American, and Japanese manufacturers [3] - The company is focused on the research and production of next-generation liquid helium-free superconducting magnets and 1.5T large aperture liquid helium-free superconducting magnets [3] - In the past three years, the company's net profit has been 425 million yuan, with a projected revenue of 451 million yuan in 2023, reflecting a growth of 25.55% [3]